BLUE

bluebird bio (BLUE)

About bluebird bio (BLUE)

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Details

Daily high

$9.80

Daily low

$7.94

Price at open

$9.20

52 Week High

$38.40

52 Week Low

$5.80

Market cap

82.6M

Dividend yield

0.00%

Volume

900,856

Avg. volume

740,883

P/E ratio

-.24

bluebird bio News